← Back to all trials
Active Not Recruiting
NCT03270072
The Differential Impact of Proton Beam Irradiation Versus Conventional Radiation on Organs-at-risk in Stage II-III Breast Cancer Patients
Conditions: Breast Cancer Stage II, Breast Cancer Stage III
Sex: All
Ages: 21 Years – N/A
Healthy volunteers: No
Enrollment: 100
Sponsor: Massachusetts General Hospital
Location: Massachusetts General Hospital Boston Massachusetts
Summary
The objective of the study is to serve as a correlative study for patients enrolled on the RadCOMP trial (NCT02603341), a randomized phase III study of stage II and III breast cancer patients treated with either conventional photon radiation or proton beam radiation
Eligibility Criteria
Inclusion Criteria:
* Eligible for and scheduled to receive radiation therapy on Radiation Therapy Oncology Group (RTOG) Trial 3510 (Pragmatic Phase III Randomized Trial of Proton vs Photon Therapy for Patients with Non-Metastatic Breast Cancer Receiving Comprehensive Nodal Radiation: A Radiotherapy Comparative Effectiveness (RADCOMP) Consortium Trial). (NCT02603341)
* Ability to understand and the willingness to sign a study-specific written informed consent document
Exclusion Criteria:
* There are no exclusion criteria.
Source: ClinicalTrials.gov (NCT03270072). StuddyBuddy aggregates publicly available trial information.
